These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7528029)

  • 1. Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
    Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Droz JP
    Eur J Cancer; 1994; 30A(9):1239-44. PubMed ID: 7528029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for ovarian germ cell tumours.
    Bower M; Fife K; Holden L; Paradinas FJ; Rustin GJ; Newlands ES
    Eur J Cancer; 1996 Apr; 32A(4):593-7. PubMed ID: 8695258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
    Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
    Ledermann JA; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Brampton M
    Br J Urol; 1994 Aug; 74(2):225-30. PubMed ID: 7522874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of malignant ovarian germ cell tumor and sex cord tumors].
    Sugiyama T; Ohta S; Tomonari R; Kamura T
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1358-62. PubMed ID: 12214461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POMB/ACE chemotherapy for mediastinal germ-cell tumours.
    Droz JP
    Eur J Cancer; 1997 May; 33(6):809-11. PubMed ID: 9291797
    [No Abstract]   [Full Text] [Related]  

  • 9. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
    Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
    Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
    Bower M; Newlands ES; Holden L; Rustin GJ; Begent RH
    Ann Oncol; 1997 May; 8(5):477-83. PubMed ID: 9233528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
    Hong W; Zhang R; Liu L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA; Bulanov AA; Titov DA; Sokolov AV; Sholokhov VN; Garin AM
    Urol Nefrol (Mosk); 1996; (2):26-9. PubMed ID: 8677548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian germ cell malignancies: the Yale University experience.
    Schwartz PE; Chambers SK; Chambers JT; Kohorn E; McIntosh S
    Gynecol Oncol; 1992 Apr; 45(1):26-31. PubMed ID: 1376294
    [No Abstract]   [Full Text] [Related]  

  • 16. Germ cell tumors in children: gonadal and extragonadal.
    Wollner N; Ghavimi F; Wachtel A; Luks E; Exelby P; Woodruff J
    Med Pediatr Oncol; 1991; 19(4):228-39. PubMed ID: 1711647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant germ cell tumors in childhood.
    Nair R; Pai SK; Saikia TK; Nair CN; Kurkure PA; Gopal R; Sampat MS; Advani SH
    J Surg Oncol; 1994 Jul; 56(3):186-90. PubMed ID: 7518019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cisplatinum, vinblastine, bleomycin, and etoposide in the therapy of malignant nondysgerminomatous germ cell tumors of the ovary.
    von Eyben FE
    Gynecol Oncol; 1995 Jul; 58(1):143. PubMed ID: 7540585
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
    Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
    Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.